7-100401169-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001386010.1(ZCWPW1):c.1795G>A(p.Glu599Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000613 in 1,614,268 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001386010.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZCWPW1 | NM_001386010.1 | c.1795G>A | p.Glu599Lys | missense_variant | 18/18 | ENST00000684423.1 | NP_001372939.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZCWPW1 | ENST00000684423.1 | c.1795G>A | p.Glu599Lys | missense_variant | 18/18 | NM_001386010.1 | ENSP00000507762.1 | |||
ENSG00000289690 | ENST00000695708.1 | c.-1208+1557C>T | intron_variant | ENSP00000512108.1 |
Frequencies
GnomAD3 genomes AF: 0.000374 AC: 57AN: 152264Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000722 AC: 18AN: 249414Hom.: 0 AF XY: 0.0000591 AC XY: 8AN XY: 135318
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461886Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 16AN XY: 727242
GnomAD4 genome AF: 0.000374 AC: 57AN: 152382Hom.: 0 Cov.: 32 AF XY: 0.000403 AC XY: 30AN XY: 74516
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2024 | The c.1792G>A (p.E598K) alteration is located in exon 18 (coding exon 16) of the ZCWPW1 gene. This alteration results from a G to A substitution at nucleotide position 1792, causing the glutamic acid (E) at amino acid position 598 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at